Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of AE-37 in patients with breast cancer.

Trial Profile

Phase I trial of AE-37 in patients with breast cancer.

Phase of Trial: Phase I

Latest Information Update: 23 Jun 2008

At a glance

  • Drugs AE 37 (Primary)
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Sponsors Generex Biotechnology Corporation
  • Most Recent Events

    • 23 Jun 2008 Results will be published in the Journal of Clinical Oncology.
    • 03 Jun 2008 Final results presented at the Annual Meeting of the American Society of Clinical Oncology 2008.
    • 17 Dec 2006 Results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top